Advanced treatments for kidney failure offers patients improved survival rates and quality of life. Discover the options from ...

The National Kidney Foundation (NKF) is proud to announce that its KidneyCARE (Community Access to Research Equity)™ Study – ...

For millions living with rare diseases, the road to diagnosis and treatment is often filled with uncertainty. It is also similar with patients that are diagnosed with rare kidney disorders as these ...

autosomal dominant tubulointerstitial kidney disease, focal segmental glomerulosclerosis, Alport syndrome, and atypical ...

Alexander's health issues began when he was diagnosed with Alport syndrome at age 17. The inherited disease causes damage to the blood vessels in the kidney, which can lead to hearing loss ...

RG-012 is an anti-miR targeting miR-21 in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease. RGLS4326 is an anti-miR targeting miR-17 in Phase I ...

It was also developing an miR-21 oligonucleotide called lademirsen for another genetic disease affecting the kidneys, Alport syndrome, but that was abandoned in 2022 and rights returned to Regulus ...

C3 Glomerulopathy (C3G), Focal Segmental Glomerulosclerosis (FSGS), Polycystic Kidney Disease (PKD), Alport Syndrome, Fabry Disease, and more. By capturing diverse patient experiences, the study ...